cdmo.directory
← Compare landing

Artis BioSolutions vs Emergent BioSolutions CDMO

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryArtis BioSolutionsEmergent BioSolutions CDMO
SummaryIntegrated CDMO platform combining proprietary enzymatic synthetic DNA production with advanced therapy development and GMP manufacturing for mRNA, gene editing, viral vectors, cell therapies, and vaccines.Leading public health company specializing in medical countermeasures, commercial products, and strategic manufacturing partnerships for biodefense and public health preparedness.
Services
  • Upstream Processing
  • Downstream Processing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Cell Therapy Manufacturing
  • mRNA Manufacturing
  • Vaccine Manufacturing
  • Process Development
  • Technology Transfer
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Technology Transfer
Modalities
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
  • Biologics (Other)
  • Vaccine
Development capabilitiesData not yet provided.Data not yet provided.
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
Locations
  • Headquarters & Manufacturing, Watertown, MA, United States
  • Manufacturing, Bilbao, Spain
  • Headquarters, Gaithersburg, Maryland, United States
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Artis BioSolutions alternatives · Emergent BioSolutions CDMO alternatives

Markdown mirror: /compare/artis-biosolutions/emergentbiosolutions.md